What are the advantages of pemetinib/pemetinib in treating certain types of cancer?

Pemigatinib/Pemigatinib has significant advantages in the treatment of certain types of cancer. As an FGFR inhibitor, it can accurately target cancer cells with FGFR gene mutations, effectively inhibit their growth and spread, and improve treatment efficiency. Compared with traditional chemotherapy, pemetinib has fewer side effects, is better tolerated by patients, and improves quality of life. Especially for refractory malignant tumors such as cholangiocarcinoma, pemetinib has shown excellent efficacy, providing these patients with new treatment options and hope for survival. Therefore, pemetinib plays an important role in the anti-cancer field, and its advantage lies in its precise, efficient and safe therapeutic properties.